In conclusion, we have demonstrated that the neuroprotective effects of nicotine in animal and cellular models of PD is mediated by activation of α7 nAChR and the inhibition of PARP-1 and caspase-3 cleavage. The gene discussed is CASP3; the disease is Parkinson disease.